Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-03

Clinical Trial Update: L-Arginine, Symmetrical and Asymmetrical Dimethylarginine (SDMA/ADMA) in Acute Kidney Injury (AKI)

View source ↗

Summary

A completed clinical trial evaluating the effect of L-Arginine and the arginine metabolites SDMA/ADMA in acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Acute Kidney Injury | Status: COMPLETED